|
HOME |
2010 Senior Symposium
Program
|
The CT Chapter of ASCP
presents an annual Senior Symposium, a forum to
educate, update and provide networking with
professionals dedicated to caring for our
elderly. This meeting is not just for Senior
Care Pharmacists but also is appropriate for all
members of the geriatric interdisciplinary team
including Doctors, Nurses, Social Workers, Home
Care professionals, Rehabilitative Therapists,
Geriatric Living Facility Directors and
Administrators and many more...
|
|
|
|
|
Thursday, April
8th |
|
12:00
noon
Registration Opens
Location: Pre-Function 1 |
1:45pm -
3:15 pm
LAW CE:
An Update for
Long-term Care Pharmacists
ACPE#009-999-10-010-L03-P
0.15 CEU
(1.5 contact hours)
-
Knowledge-based CE
Speakers:
John Cannarella, RPh; John Gadea, RPh;
Mike Gemma, RPh; Kevin Hill; Gene Memoli, RPh;
Larry Sobel, RPh
Location:
Premier GH
Learning Objectives
Identify the
reason(s) for new legislation for the
prescribing of controlled substances in
long-term care environments
Describe the recent and pending legislation
impacting pharmacy practice in long-term care
for 2010
|
3:15pm -
3:30 pm
Break |
3:30 pm -
4:30 pm
CT-ASCP Board of
Directors
Transition (ASCP
members)
Location:
Premier F |
|
4:30 pm -
5:45 pm
Pre-Dinner
Reception
(Non-CE Event)
Understanding Gout as a Chronic Disease
Speaker: Joseph Croft MD
Location: Premier A
Sponsored by TAKEDA Pharmaceutical Company |
5:45 pm -
6:30 pm
Dinner &
opening Remarks
Location:
Premier BD |
|
6:30 pm - 8:00 pm
Hypertension in the Elderly: Too Little, Too Late?
ACPE #009-999-10-011-L01-P 0.15CEU (1.5
contact hours)
-
Knowledge-based CE
Speakers: Marvin Moser, MD
Learning Objectives
Identify barriers to the
optimal care of the elderly patient with hypertension
and other comorbidities
Critically analyze both the risk and benefit
of current treatments for hypertension in the elderly
patient with
hypertension and other geriatric syndromes
Describe how to initiate discussion of the
risks and benefits of treatment and total costs in older
patients
with hypertension and other comorbidities
This presentation is generously supported by an
educational grant
from FOREST Laboratories., Inc.
download
handout
 |
8:30 pm
Evening at Shrine Lounge & Nightclub
-
Networking |
|
Friday, April
9th |
5:30 am
Registration Opens
Location: Pre-Function 1 |
6:00 am -
7:00 am
Eye Opener:
A Case Study in Chronic
Low Back Pain
Pain Management with Skeletal Muscle
Relaxants and Non-opioid Analgesics
ACPE #:
009-999-10-012-L01-P 0.1 CEU (1
contact hour)
-
Application-based CE
Speaker:
Kevin W. Chamberlin, PharmD
Location:
Premier A
Learning Objectives
Identify common misconceptions about chronic
back pain patients and treatment with
prescription non-opioid
analgesics and skeletal muscle relaxants (SMRs)
Describe differences and barriers surrounding
choices between prescription non-opioid
analgesics and skeletal muscle relaxants
(SMRs) used in chronic back pain management
download
handout
 |
7:00 am -
8:00 am
Breakfast Product
Theater 1
(Non-CE Event)
Neuropathic Pain of Postherpetic Neuralgia
and Herpes Zoster
Integrating New Clinical Data into a
Comprehensive PHN Pain Management
Patient Presentation: 73-year-old retired,
previously active, man with ongoing sharp pain
with skin sensitivity.
Speaker: Michael J.. Brennan MD
Locations: Premier EF
Sponsored by ENDO Pharmaceuticals
7:00 am -
8:00 am
Breakfast Product
Theater 2
(Non-CE Event)
Topic: TBA
Speaker: TBA
Locations: Premier GH
Sponsored by AMGEN |
8:15 am -
9:45 am
Opening General
Session
LAW CE
Here Come the Feds: Understanding Washington's
Increasing Role in Pharmacy Practice
ACPE#009-999-10-013-L03-P
0.15 CEU
)(1.5
contact hours)
-
Knowledge-based CE
Speaker:
Claudia Schlosberg,
JD
Location: Premier BD
Learning Objectives
Recall the historic role of the federal
government in the regulation of pharmacy and the
key drivers that are contributing
to a more active role
Identify significant current issues that have
the potential to change pharmacy practice and
the challenges and opportunities
that pharmacists and pharmacies are likely to face
Identify tools to help you be more effective
in communicating with policy makers regarding
the critical role that pharmacists
play in our health care system
download
handout

|
9:45pm -
10:00 am
Break
Location: Exibit hall |
10:00 am -
11:30am
Second General
Session
Annual Timothy Webster Memorial Address:
What Comes Next? New Models of Practice - New
Models of Care
ACPE
#009-999-10-014-L04-P
0.15 CEU
(1.5 contact hours)
-
Knowledge-based CE
Speaker:
William Thomas, MD
Location: Premier BD
Learning Objectives
Describe how aging is transforming the healthcare system
Define the central role that Pharmacists will play on
managing patients with multiple co-morbidities
Explain the opportunities for innovation and exploration
within the health care system
|
11:30 am -
1:00 pm
Product Theater Luncheon 1
(Non-CE Event)
Location: Premier EF
Sponsored by TAKEDA Pharmaceutical Company
Treatment of Chronic Constipation in the
Elderly
Speaker:
Dana Saffel, PharmD
11:30 pm -
1:00 pm
Product Theater Luncheon 2
(Non-CE Event)
Location: Premier GH
Sponsored by CENTOCOR ORTHO BIOTECH
Anemia Identification & Management in the
Elderly
Overview:
Anemia is prevalent in
the long‐term care setting and is undiagnosed
and may not be treated. Anemia
is not a normal part of aging and is an
important disease that may be associated with
negative
outcomes. Causes of anemia include decreased red
blood cell production, increased red blood cell
destruction, and blood loss. This presentation
will address appropriate identification,
assessment and
management of anemia in the elderly population
Learning Objectives:
Highlight the prevalence of anemia in the
elderly and in the long‐term care (LTC) setting
Provide an overview of the consequences and
associations of anemia in the elderly
Review the workup and management of anemia
Discuss LTC‐related considerations in the
identification and management of anemia
|
1:00 pm -
2:00 pm
General Session
New Medications, New generics, New FDA
labeling... More Work
ACPE
#009-999-10-015-L01-P
0.1 CEU (1 contact hour)
-
Knowledge-based CE
Speaker:
Nancy Losben, RPh
Location: Premier BD
Learning
Objectives
Explain the initiatives of the FDA Risk
Evaluation and Mitigation Strategies
Describe how to monitor patients for dose,
adverse effects and drug-drug interactions using
new drugs to treat chronic disease
Outline how to appropriately distribute and/or
use FDA approve medication guides in the
assisted living population
Describe how to use new drug labeling warnings
in monitoring drug side effects
Explain how to access readily available new
drug information as soon as available
download
handout
 |
2:00 pm -
3:00 pm
Exhibit Hall &
Dessert
Location: Exhibit Hall |
3:00 pm -
4:00 pm
When is
Anticoagulation Worth the Risk? Managing Older
Atrial Fibrillation Patients
ACPE #009-999-10-016-L01-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speaker:
Sean Jeffery, PharmD
Location: Premier A
Learning Objectives
Describe the risks and benefits of
treatment options, including warfarin
alternatives
Describe the co-morbidities and geriatric
syndromes common among older adults
with AF and understand the need to take
an individualized management approach to
care
Discuss the management of AF
pharmacologically with the awareness of
polypharmacy issues
download
handout

|
3:00 pm -
4:00 pm
Compounding:
Custom Dosage
Forms for Long-term Care Patients
ACPE #009-999-10-017-L04-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speakers:
Robin Bogner, PhD
Michael Lettmoden, PharmD
Location: Premier EF
Learning Objectives
Describe how compounding can help
develop customized dosage forms for
delivering medications to challenging
patients
Demonstrate how to establish beyond
use dates for extemporaneously
compounded medications
download
handout
 |
3:00 pm -
4:00 pm
Why Adults Only? The Public Health case for
Adult Immunization
ACPE #009-999-10-018-L04-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speaker:
Thomas Buckley, RPh, MPH
Location: Premier GH
Learning Objectives
Describe the cost-effective impact of
immunization
Explain the reasons for the vaccination
gap between child and adult immunization
Describe the role of pharmacists in
immunization advocacy
Identify and resolve public health
immunization issues
download
handout

|
4:00 pm -
4:15 pm Break |
4:15 pm -
5:15 pm
Health Literacy &
Aging
ACPE #009-999-10-019-L04-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speakers:
Erica Estus, PharmD
Location: Premier A
Learning Objectives
Define health literacy and discuss the
significance of the age related changes
that occur in older adults
Summarize evidence regarding the
relationship between literacy and health
outcomes in specific disease processes
Discuss strategies, tools, and materials
intended to improve communication
between patients and providers
download
handout

|
4:15 pm -
5:15 pm
Medication Errors:
The Drug Use
Process & the Elderly
ACPE
#009-999-10-020-L05-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speaker:
Dennis Chapron, RPh,
MS
Location: Premier EF
Learning Objectives
Explain the difference between an adverse
drug event, adverse drug reactions, and a
medication error
List the components of the drug use
process that are not involved in the
medication errors.
Describe a process for evaluating a
patients medication profile and its risk for
causing an adverse drug event
Describe some breakdown points that may
lead to omissions-type medication errors
Develop a drug monitoring process for
lithium, amiodarone, and methotrexate.
download
handout
 |
4:15 pm -
5:15 pm
Topic:
DNA Guided Psychotropic
Management
ACPE
#009-999-10-021-L04-P
0.10 CEU
(1 contact hour)
Knowledge-based CE
Speaker:
Gualberto Ruano, MD, PhD
Location: Premier GH
Learning Objectives
Recognize the clinical utility of cytochrome
P450 (CYP450) genotyping in management
of psychiatric drugs
Recognize the case presentations and
patient profiles where use of CYP450
genotyping can diagnose clinically intensive
side effects
Identify healthcare utilization patterns in
patients with CYP450 drug metabolism
deficiencies
Recall the features of next-generation
multi-genotype arrays to diagnose and
prevent the cardiometabolic and
neuroendocrine side effects of
antipsychotic drugs
download
handout

|
|
|
|
|